Recent bioinformatic analyses indicate that dysregulated expression of GPC5-AS1 is associated with several tumors, such as metastatic melanoma [21], renal cell cancer [22, 23], astrocytoma [24], and meningioma [25]. This evidence concerns the gene GPC5 and renal cell adenocarcinoma.